Barely Significant
← all excerpts

Analyses of the Efficacy and Safety of Antifibrotic Therapies in Non-IPF Pulmonary Fibrosis, Progressing Despite Management.

Ann Am Thorac Soc · 2022 · PMC9169120 · PMID 35648081

Europe PMCDOI
1
hedged sentence
0.4100
closest p · 8.2× alpha
0.4100
boldest claim

The sentences

marginally significantP = 0.41not close (p > 0.1)
No significant or marginally significant differences in efficacy between disease subgroups were observed (treatment-by-subgroup-by-time interaction; P = 0.41).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.